Cambridge Biotech Firm Secures $60M for RNA Editing Therapies - Funding Raised

Cambridge Biotech Firm Secures $60M for RNA Editing Therapies

Cambridge-based biotech company AIRNA has closed a $60 million financing round, bringing its total Series A funding to $90 million. Led by Forbion with new and existing investors, the funds will advance AIRNA’s lead RNA editing therapeutic into clinical trials and further develop its pipeline.

Latest News

Read More

BlissClub

BlissClub Funding D2C Athleisure Brand ने जुटाए ₹160 करोड़,

BlissClub ने Singularity AMC के नेतृत्व में ₹160 करोड़ Series B funding जुटाई। जानिए founders, revenue, loss, business

By Vaishali Sharma

PayGlocal

PayGlocal Funding $120 Million Valuation पर जुटाएगा ₹36 करोड़,

PayGlocal $120 million valuation पर ₹36.38 करोड़ जुटाने जा रहा है। जानिए funding, founders, revenue, RBI licence, business

By Vaishali Sharma

Benne

Benne Funding Bengaluru-Style Dosa Chain ने जुटाए ₹35 करोड़,

Benne ने ₹35 करोड़ की Pre-Series A funding जुटाई है। जानिए Claypond Capital investment, ₹364 करोड़ valuation, founders,

By Vaishali Sharma